Another recently discovered small molecule, TEC-1, with a similar chemical structure to risdiplam, has demonstrated increased SMN expression, increased lifespan, and improved motor phenotypes in a severe SMA mouse model, with fewer off-target splicing changes than risdiplam.49 The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.